Current Good Manufacturing

Ranbaxy was hit with another import alert from the FDA on Monday.

Update

US FDA punishes Ranbaxy again with another import alert

By Zachary Brennan

After finding cGMP violations at another Ranbaxy plant in India, the US FDA on Monday issued an import alert that effectively stops all of the plant’s drug shipments from entering the US.

Spotlight

Follow us

Webinars

Featured Suppliers

All